Literature DB >> 9749587

Levodopa toxicity and apoptosis.

E Melamed1, D Offen, A Shirvan, R Djaldetti, A Barzilai, I Ziv.   

Abstract

Many in vitro studies have shown that levodopa is a potent toxin which is lethal to various cultured neuronal and non-neuronal cells. The in vitro toxicity of levodopa is linked mainly to its auto-oxidation, which generates a variety of harmful free radical species including superoxide, hydrogen peroxide, and hydroxyl radicals, and also semiquinones and quinones produced via the dopa-melanin metabolic route. Such toxic effects of levodopa can be blocked by co-treatment with antioxidants, particularly thiol-containing compounds. Several studies have shown that levodopa kills cells by triggering apoptosis, an active, intrinsic cell suicide program. Exposure of cultured neurons to levodopa induced the characteristic apoptotic cascade, including cell shrinkage, membrane blebbing, and nuclear and DNA fragmentation. Although levodopa is extremely toxic in vitro, there is no evidence that it damages nigrostriatal dopaminergic neurons in vivo in experimental animals and in patients with Parkinson's disease (PD). Likewise, although there is some evidence for the occurrence of apoptosis in the parkinsonian substantia nigra, it is not known whether levodopa administration is capable of inducing or accelerating programmed cell death of residual pigmented nigral neurons in PD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9749587     DOI: 10.1002/ana.410440722

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

1.  Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis.

Authors:  A Hartmann; J D Troadec; S Hunot; K Kikly; B A Faucheux; A Mouatt-Prigent; M Ruberg; Y Agid; E C Hirsch
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

2.  Involvement of reactive oxygen species generated from melanin synthesis pathway in phytotoxicty of L-DOPA.

Authors:  Mayumi Hachinohe; Hiroshi Matsumoto
Journal:  J Chem Ecol       Date:  2005-02       Impact factor: 2.626

3.  BL-1023 improves behavior and neuronal survival in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice.

Authors:  J A L Hutter-Saunders; L M Kosloski; J M McMillan; N Yotam; T Rinat; R L Mosley; H E Gendelman
Journal:  Neuroscience       Date:  2011-02-12       Impact factor: 3.590

Review 4.  Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease.

Authors:  Dirk Deleu; Margaret G Northway; Yolande Hanssens
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  The role of 3-O-methyldopa in the side effects of L-dopa.

Authors:  Eun-Sook Y Lee; Hongtao Chen; Jennifer King; Clivel Charlton
Journal:  Neurochem Res       Date:  2007-08-24       Impact factor: 3.996

6.  Experimental study on inhibition of neuronal toxical effect of levodopa by ginkgo biloba extract on Parkinson disease in rats.

Authors:  Fei Cao; Shenggang Sun; E-tang Tong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

7.  Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia.

Authors:  Christine Konradi; Jenny E Westin; Manolo Carta; Molly E Eaton; Katarzyna Kuter; Andrzej Dekundy; Martin Lundblad; M Angela Cenci
Journal:  Neurobiol Dis       Date:  2004-11       Impact factor: 5.996

8.  Ghrelin is neuroprotective in Parkinson's disease: molecular mechanisms of metabolic neuroprotection.

Authors:  Jacqueline A Bayliss; Zane B Andrews
Journal:  Ther Adv Endocrinol Metab       Date:  2013-02       Impact factor: 3.565

9.  Coating Dependent In Vitro Biocompatibility of New Fe-Si Nanoparticles.

Authors:  Mihaela Balas; Florian Dumitrache; Madalina Andreea Badea; Claudiu Fleaca; Anca Badoi; Eugenia Tanasa; Anca Dinischiotu
Journal:  Nanomaterials (Basel)       Date:  2018-07-05       Impact factor: 5.076

10.  Evolution of Initial Pharmacologic Treatment of Newly Diagnosed Parkinson's Disease Patients over a Decade in Singapore.

Authors:  Shermyn Neo; Sheng Yong Aidan Wong; Hwee Lan Ng; Wei Li; Kay Yaw Tay; Wing Lok Au; Louis Chew Seng Tan
Journal:  Parkinsons Dis       Date:  2020-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.